BioNTech SE ROI - Return on Investment 2019-2025 | BNTX

BioNTech SE return on investment for the quarter ending March 31, 2025 was -3.91.

  • BioNTech SE average return on investment for 2024 was -1.9, a 110.95% increase from 2023.
  • BioNTech SE average return on investment for 2023 was 17.35, a 78.72% decline from 2022.
  • BioNTech SE average return on investment for 2022 was 81.52, a 42.82% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

BioNTech SE ROI - Return on Investment 2019-2025 | BNTX

  • BioNTech SE average return on investment for 2024 was -1.9, a 110.95% increase from 2023.
  • BioNTech SE average return on investment for 2023 was 17.35, a 78.72% decline from 2022.
  • BioNTech SE average return on investment for 2022 was 81.52, a 42.82% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.